8.90
-0.04
(-0.45%)
At close: 3:00:01 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
6,081,815.31
6,146,721.44
5,621,441.90
4,923,783.87
4,205,109.10
Cost of Revenue
4,645,572.84
4,631,268.20
4,373,961.98
3,746,104.85
3,224,976.98
Gross Profit
1,436,242.46
1,515,453.24
1,247,479.93
1,177,679.02
980,132.12
Operating Expense
1,030,239.17
1,122,879.10
954,394.88
934,819.97
820,839.76
Operating Income
406,003.29
392,574.15
293,085.05
242,859.05
159,292.36
Net Non Operating Interest Income Expense
-75,008.21
-74,154.50
-97,694.37
-63,136.02
-56,548.01
Pretax Income
423,464.81
272,975.17
150,095.36
113,578.62
262,161.19
Tax Provision
9,704.55
16,187.88
6,980.38
23,687.28
28,676.20
Net Income Common Stockholders
400,678.77
246,171.80
138,013.13
89,098.69
227,876.52
Basic EPS
0.45
0.28
0.16
0.10
0.26
Diluted EPS
0.45
0.28
0.15
0.10
0.25
Basic Average Shares
890,179.63
879,184.99
862,582.06
890,986.92
876,448.14
Diluted Average Shares
890,179.63
879,184.99
920,087.53
890,986.92
911,506.07
Total Operating Income as Reported
423,493.46
272,133.45
148,773.70
116,018.54
264,884.83
Total Expenses
5,675,812.01
5,754,147.29
5,328,356.86
4,680,924.82
4,045,816.74
Net Income from Continuing & Discontinued Operation
400,678.77
246,171.80
138,013.13
89,098.69
227,876.52
Normalized Income
308,601.78
290,071.49
194,773.42
132,933.06
75,817.23
Interest Income
11,320.24
8,941.61
7,188.39
6,325.47
8,975.26
Interest Expense
81,183.05
79,174.66
98,043.42
65,129.51
63,348.39
Net Interest Income
-75,008.21
-74,154.50
-97,694.37
-63,136.02
-56,548.01
EBIT
504,647.86
352,149.83
248,138.78
178,708.13
325,509.58
EBITDA
504,647.86
733,276.64
596,261.13
486,169.04
569,443.88
Reconciled Cost of Revenue
4,645,572.84
4,631,268.20
4,373,961.98
3,746,104.85
3,224,976.98
Reconciled Depreciation
--
381,126.81
348,122.35
307,460.91
243,934.29
Net Income from Continuing Operation Net Minority Interest
400,678.77
246,171.80
138,013.13
89,098.69
227,876.52
Total Unusual Items Excluding Goodwill
94,236.62
-46,667.13
-59,528.75
-55,385.17
170,734.93
Total Unusual Items
94,236.62
-46,667.13
-59,528.75
-55,385.17
170,734.93
Normalized EBITDA
410,411.24
779,943.77
655,789.88
541,554.21
398,708.95
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
2,159.62
-2,767.44
-2,768.46
-11,550.80
18,675.64
12/31/2020 - 2/26/1997
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
002437.SZ HARBIN GLORIA PHARMACEUTICALS Co., LTD
2.4900
-0.80%
600664.SS Harbin Pharmaceutical Group Co., Ltd.
3.7100
0.00%
002370.SZ Zhejiang Yatai Pharmaceutical Co., Ltd.
3.2800
+0.31%
002390.SZ Guizhou Xinbang Pharmaceutical Co., Ltd.
3.9300
-5.76%
TRILC.IS Turk Ilac Ve Serum Sanayi Anonim Sirketi
17.34
-1.48%
600518.SS Kangmei Pharmaceutical Co., Ltd.
2.2200
0.00%
PYFA.JK PT Pyridam Farma Tbk
216.00
-1.82%